Alloy Therapeutics
Alloy Therapeutics52
About
What does Alloy Therapeutics do?
Alloy Therapeutics is a biotechnology ecosystem company focused on accelerating drug discovery and development. They leverage AI-driven platforms and integrated services to support the entire process, evolving from an antibody discovery pioneer to a full-stack biotech infrastructure provider. Their offerings aim to streamline and enhance the efficiency of bringing new therapeutics to market.
What is Alloy Therapeutics's revenue?
StartupHub estimates Alloy Therapeutics's annual revenue at $73.3M (range $32.8M to $207.3M, 44% confidence), based on comparable companies in the sector.
What is Alloy Therapeutics's valuation?
StartupHub estimates Alloy Therapeutics's effective valuation at $419.2M (range $146.7M to $1.1B, 56% confidence), based on comparable companies in the sector.
How much funding has Alloy Therapeutics raised?
Alloy Therapeutics has raised a total of $157M in funding. The most recent round on record is Series E.
Where is Alloy Therapeutics headquartered?
Alloy Therapeutics is headquartered in Boston, Massachusetts, USA.
When was Alloy Therapeutics founded?
Alloy Therapeutics was founded in 2017.
What industry does Alloy Therapeutics operate in?
Alloy Therapeutics operates in Biotechnology, Artificial Intelligence, Drug Discovery, Drug Development, Biotech, MedTech.
No comments yet. Be the first to share your take.